MarginsXMarginsX
Home › Markets › Health Care › ACIU

AC Immune SA (ACIU)

ACIU trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.09
-1.88% on the day
Market cap
$212.7M
Micro cap
Revenue · 2025
$4.3M
-86.9% on 2024
Net income · 2025
-$84.0M
-1971.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1651625/000110465926027342/0001104659-26-027342-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31. Converted from CHF at 0.8384 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerACIU on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountrySwitzerland
IPO year2016
SEC CIK0001651625
SEC industry codePharmaceutical Preparations
Incorporated inSwitzerland

Financials · 2025

LineValue
Revenue$4.3M
Net income-$84.0M
Operating income-$82.7M
Net margin-1971.6%
Operating margin-1940.1%
Revenue growth-86.9%
Cash$32.0M
Total assets$184.0M
P/E (computed)Net income was not positive
P/S (computed)49.9×

Reported in CHF; shown in US dollars.

Warning signs

Cash runway
4.6 months
26.8M CHF cash at December 31, 2025
Share count, 1 year
+1.3%
2024-12-31 to 2025-12-31 · +21.7% over 3 years
Going-concern doubt
No
20-F filed March 13, 2026
Insider net buying, 12 months
-$28K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-13
Cash and burn26.8M CHF cash; operating cash flow -17.3M CHF a quarter.Report 2025-12-31
Shares outstanding101,742,231 (2025-12-31); 100,410,377 a year earlier; 83,620,364 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers AG, Lausanne, SwitzerlandPCAOB Form AP 2026-03-31
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $31K, sold $59K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
3.6M CHF-70.4M CHF-69.3M CHF26.8M CHFNo debt tags3.6M CHF20-F 2026-03-13
FY 2024
2024-12-31
27.3M CHF-50.9M CHF65.8M CHF36.3M CHFNo debt tags27.3M CHF20-F 2026-03-13
FY 2023
2023-12-31
14.8M CHF-54.2M CHF-60.4M CHF78.5M CHFNo debt tags14.8M CHF20-F 2026-03-13
FY 2022
2022-12-31
3.9M CHF-70.8M CHF-73.6M CHF31.6M CHFNo debt tags3.9M CHF20-F 2025-03-13
FY 2021
2021-12-31
0 CHF-73.0M CHF-65.7M CHF82.2M CHFNo debt tags0 CHF20-F 2024-03-14
FY 2020
2020-12-31
15.4M CHF-61.9M CHF-59.5M CHF160.9M CHFNo debt tags15.4M CHF20-F 2023-03-16
FY 2019
2019-12-31
110.5M CHF45.4M CHF55.2M CHF193.6M CHFNo debt tags110.5M CHF20-F 2022-03-22
FY 2018
2018-12-31
6.9M CHF-51.0M CHF-44.1M CHF156.5M CHFNo debt tags6.9M CHF20-F 2021-03-23

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CHF.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52024-08-06
Latest annual report20-F2026-03-13
Latest quarterly / interim6-K2026-11-04

Source: SEC EDGAR submissions feed, 313 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.5%
1 month-11.3%
3 months-17.1%
Year to date-32.2%
1 year-34.1%
From 52-week high-42.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
YARWYarrow Bioscience Inc.$13.93-22.74%$212.2M
VOGXVogenx Inc$14.38-13.74%$213.6M
CYPHCypherpunk Technologies Inc.$1.93+2.94%$207.4M
SIGASIGA Technologies Inc.$2.85+4.01%$204.8M
DRUGBright Minds Biosciences Inc.$22.61-2.16%$222.0M
BCYCBicycle Therapeutics plc$3.18-5.64%$222.9M
GLSIGreenwich LifeSciences Inc.$13.76-7.90%$202.0M
IMRXImmuneering Corporation$3.52-5.12%$228.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier